PROCTER & GAMBLE HEALTH | SUVEN LIFE SCIENCES | PROCTER & GAMBLE HEALTH/ SUVEN LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.3 | -22.6 | - | View Chart |
P/BV | x | 10.5 | 6.4 | 163.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH SUVEN LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SUVEN LIFE SCIENCES Mar-23 |
PROCTER & GAMBLE HEALTH/ SUVEN LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 94 | 5,722.7% | |
Low | Rs | 3,883 | 45 | 8,627.0% | |
Sales per share (Unadj.) | Rs | 740.7 | 0.6 | 119,308.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | -5.4 | -2,548.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -5.1 | -3,028.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 17.2 | 2,600.8% | |
Shares outstanding (eoy) | m | 16.60 | 218.07 | 7.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 111.8 | 5.6% | |
Avg P/E ratio | x | 33.5 | -12.8 | -261.5% | |
P/CF ratio (eoy) | x | 29.8 | -13.5 | -220.1% | |
Price / Book Value ratio | x | 10.3 | 4.0 | 256.2% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 15,131 | 507.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 186 | 1,107.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 135 | 9,082.1% | |
Other income | Rs m | 184 | 84 | 217.7% | |
Total revenues | Rs m | 12,480 | 220 | 5,675.9% | |
Gross profit | Rs m | 3,247 | -1,196 | -271.4% | |
Depreciation | Rs m | 281 | 65 | 429.5% | |
Interest | Rs m | 8 | 5 | 143.1% | |
Profit before tax | Rs m | 3,142 | -1,183 | -265.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | - | |
Profit after tax | Rs m | 2,295 | -1,183 | -194.0% | |
Gross profit margin | % | 26.4 | -883.6 | -3.0% | |
Effective tax rate | % | 27.0 | 0 | - | |
Net profit margin | % | 18.7 | -873.5 | -2.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,455 | 339.0% | |
Current liabilities | Rs m | 6,791 | 1,050 | 646.6% | |
Net working cap to sales | % | 40.0 | 1,776.0 | 2.3% | |
Current ratio | x | 1.7 | 3.3 | 52.4% | |
Inventory Days | Days | 263 | 3,948 | 6.7% | |
Debtors Days | Days | 343 | 218 | 157.8% | |
Net fixed assets | Rs m | 10,617 | 1,373 | 773.1% | |
Share capital | Rs m | 166 | 218 | 76.1% | |
"Free" reserves | Rs m | 7,265 | 3,535 | 205.5% | |
Net worth | Rs m | 7,431 | 3,753 | 198.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 4,828 | 462.5% | |
Interest coverage | x | 409.1 | -218.8 | -186.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0 | 1,963.7% | |
Return on assets | % | 10.3 | -24.4 | -42.3% | |
Return on equity | % | 30.9 | -31.5 | -98.0% | |
Return on capital | % | 42.4 | -31.4 | -135.1% | |
Exports to sales | % | 0 | 40.4 | 0.0% | |
Imports to sales | % | 13.1 | 839.8 | 1.6% | |
Exports (fob) | Rs m | NA | 55 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,137 | 141.2% | |
Fx inflow | Rs m | 1,465 | 55 | 2,676.2% | |
Fx outflow | Rs m | 1,605 | 1,137 | 141.2% | |
Net fx | Rs m | -140 | -1,082 | 13.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -1,031 | -228.8% | |
From Investments | Rs m | -215 | -2,606 | 8.2% | |
From Financial Activity | Rs m | -985 | 3,955 | -24.9% | |
Net Cashflow | Rs m | 1,160 | 317 | 365.5% |
Indian Promoters | % | 0.0 | 69.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 1.5 | 1,322.5% | |
FIIs | % | 6.2 | 0.5 | 1,356.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 30.4 | 158.3% | |
Shareholders | 56,778 | 68,959 | 82.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Suven Life Sciences | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.80% | -1.24% | -0.92% |
1-Month | -4.27% | 6.41% | 1.39% |
1-Year | -1.67% | 91.75% | 51.34% |
3-Year CAGR | -9.64% | 11.99% | 14.50% |
5-Year CAGR | 4.36% | -15.22% | 19.09% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Suven Life Sciences share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Suven Life Sciences.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Suven Life Sciences.
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.